Welcome to our supplement providing an excellent review of the European Association for Haemophilia and Allied Disorders (EAHAD) International Congress 2024. This supplement spotlights the key takeaways shared at the congress, an interview with a key expert, and a summary of a session on optimising outcomes on haemophilia treatment.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.